![Torsten Fahrig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torsten Fahrig
Finanzdirektor/CFO bei RESprotect GmbH
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Gouya Ram-liebig | M | 59 |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | 16 Jahre |
Rudolf Fahrig | M | 83 |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | 24 Jahre |
Sören Liebig | M | 57 |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | 19 Jahre |
Jörg-Christian Heinrich | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Klaus Kutz | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Andreas Koch | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Jürgen Bednarz | M | - |
UroTiss GmbH
![]() UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | - |
Clemens Unger | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Robert Schiestl | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Siegfried Knasmüller | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Bernhard Matter | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Herbert Müsch | M | - |
RESprotect GmbH
![]() RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Deutschland | 12 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Torsten Fahrig
- Persönliches Netzwerk